Aura Biosciences Inc (AURA) Live Share Price, Invest From India

Aura Biosciences Inc Stock Performance

as on April 18, 2026 at 6:59 am IST

Day's Low
Day's High
$7.05
Day's Price Range
$7.48
$7.29
3.29%
Downside
2.61%
Upside
52 Week's Low
52 Week's High
$4.35
52-Week Price Range
$7.48
$7.29
40.40%
Downside
2.61%
Upside

Aura Biosciences Inc share price movements today

Previous Close: $7.06
Open: $7.17
Volume: 679.8K
Day's Low - High: $7.05 - $7.48
52 Week Low - High: $4.35 - $7.48

Aura Biosciences Inc Historical Returns

1 Month Return: + 10.79 %
3 Month Return: + 45.22 %
1 Year Return: + 36.01 %
3 Year Return: -16.78 %
5 Year Return: 0 %

Aura Biosciences Inc Stock Fundamentals & Key Indicators

Check Aura Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$452.9M

EPS (TTM)

-1.6025

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-111.7M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-73.52%

Aura Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aura Biosciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Aura Biosciences Inc	BUY	$452.9M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$41.3B	122.97%	133.47	8.45%
Vertex Pharmaceuticals Inc	BUY	$110.8B	101.1%	28.42	32.94%
BeiGene, Ltd.	NA	$37.2B	NA	131.65	5.37%
Regeneron Pharmaceuticals Inc	BUY	$78.9B	49.34%	17.98	31.41%

Stock Returns calculator for Aura Biosciences Inc Stock including INR - Dollar returns

The Aura Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Aura Biosciences Inc investment value today

Current value as on today

₹1,47,337

Returns

₹47,337

(+47.34%)

Returns from Aura Biosciences Inc Stock

₹36,007 (+36.01%)

Dollar Impact

₹11,329 (+11.33%)

Analyst Recommendation on Aura Biosciences Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Aura Biosciences Inc. Average target price of $20.4

Aura Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Aura Biosciences Inc.

What analysts predicted

64.26%UPSIDE

Target Price

$20.4

Current Price

$7.29

Analyzed by

12 Analysts

Target

$20.40

Aura Biosciences Inc target price $20.4, a slight upside of 64.26% compared to current price of $7.29. According to 12 analysts rating.

Aura Biosciences Inc Stock’s Investor Sentiment and Interest

Search interest for Aura Biosciences Inc Stock has increased by 64% in the last 30 days, reflecting an upward trend in search activity.

Time period: March 20, 2026 to April 19, 2026

Change:64% versus previous 30 day period

Aura Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	2	2	-	-	1	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-20	-24	-22	-22	-23	-27	-29	-28	-27	-27
EBITDA	-20	-21	-22	-22	-22	-25	-28	-26	-25	-26
Interest Expense	-	2	2	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-18	-21	-19	-20	-20	-25	-27	-26	-26	-25
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-18	-22	-19	-20	-21	-25	-27	-27	-26	-25
Net Profit Margin	0.00%	-1076.41%	-958.46%	0.00%	0.00%	-2086.75%	0.00%	0.00%	0.00%	0.00%

Aura Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	-1	-1	-1	-
Operating Income	-24	-22	-35	-60	-84	-96	-112
EBITDA	-23	-21	-34	-59	-83	-94	-111
Interest Expense	0	0	0	0	-	-	-
Depreciation	0	0	0	1	1	1	1
Income Before Tax	-24	-22	-35	-58	-76	-86	-106
Income Tax Expense	0	0	0	-1	0	0	0
Net Income	-24	-22	-35	-58	-76	-86	-106
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Aura Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-22	-19	-20	-21	-25	-27	-27	-26	-25
Operating Cash Flow	-17	-24	-16	-15	-23	-23	-20	-20	-20
Investing Cash Flow	-90	9	19	9	29	29	19	-44	29
Financing Cash Flow	92	0	0	0	0	0	69	4	2
Change in Cash	-14	-14	3	-4	6	6	69	-59	11

Aura Biosciences Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-22	-35	-58	-76	-86	-106
Operating Cash Flow	-24	-32	-54	-63	-79	-84
Investing Cash Flow	0	-2	-67	-113	68	35
Financing Cash Flow	10	166	95	97	1	77
Change in Cash	-15	131	-26	-80	-9	27

Global Institutional Holdings in Aura Biosciences Inc

Funds	Holdings
State Street Corp	1.37%
Millennium Management LLC	0.96%
Geode Capital Management, LLC	1.96%
B Group, Inc	0.89%
Dimensional Fund Advisors, Inc.	0.81%

See all

Insights on Aura Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, AURA stock has moved up by 45.2%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.3% return, outperforming this stock by 42.2%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 40.2% return, outperforming this stock by 4.2%

About Aura Biosciences Inc

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. It focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer. The company was incorporated in 2009 and is headquartered in Boston, Massachusetts.

Organisation	Aura Biosciences Inc
Headquarters	80 Guest Street, Boston, MA, United States, 02135
Industry	Biotechnology
CEO	Dr. Elisabet de los Pinos Ph.D.
E-voting on shares	Click here to vote

Key Management of Aura Biosciences Inc

Name	Title
Dr. Elisabet de los Pinos Ph.D.	Founder, CEO, President & Director
Mr. Anthony S. Gibney	Chief Financial & Business Officer
Ms. Amy Elazzouzi	Interim Principal Accounting Officer, Senior VP of Finance & Treasurer
Dr. Mark Plavsic D.V.M., Ph.D.	Chief Technology Officer
Mr. Conor Kilroy	Chief Legal Officer & Secretary
Dr. Jill J. Hopkins M.D.	Chief Medical Officer & President of Research and Development
Mr. Patrick Nealon	Senior Vice President of Clinical Development Operations
Dr. Anthony Daniels M.D.	VP & Therapeutic Area of Head Ocular Oncology
Dr. Sabine Brookman-May	Senior VP & Therapeutic Area Head of Urologic Oncology

FAQs

What is Aura Biosciences Inc share price today?

Aura Biosciences Inc share price today is $7.29 as on April 18, 2026 at 1:29 am IST at the close of the market. Aura Biosciences Inc share today touched a day high of $7.48 and a low of $7.05.

What is the 52 week high and 52 week low for Aura Biosciences Inc share?

Aura Biosciences Inc share touched a 52 week high of $7.48 on April 17, 2026 and a 52 week low of $4.35 on May 15, 2025. Aura Biosciences Inc stock price today i.e. April 18, 2026 at 1:29 am IST is closed at $7.29,which is 2.54% down from its 52 week high and 67.78% up from its 52 week low.

What is Aura Biosciences Inc's market capitalisation today?

Aura Biosciences Inc market capitalisation is $0.00T as on April 18, 2026 at 1:29 am IST.

How to invest in Aura Biosciences Inc Stock (AURA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Aura Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aura Biosciences Inc Shares that will get you 0.2058 shares as per Aura Biosciences Inc share price of $7.29 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Aura Biosciences Inc Stock (AURA) from India?

Indian investors can start investing in Aura Biosciences Inc (AURA) shares with as little as ₹92.575 or $1 (as of April 19, 2026 at 7:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹925.75 in Aura Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on April 19, 2026 at 7:42 am IST). Based on Aura Biosciences Inc share’s latest price of $7.29 as on April 18, 2026 at 1:29 am IST, you will get 1.3717 shares of Aura Biosciences Inc. Learn more about fractional shares .